AMULET CAPITAL PARTNERS, L.P.
AMULET CAPITAL PARTNERS, L.P. is a Series C+ and buyout fund in the US and UK writing $50M–$150M checks into Healthcare, life-sciences-outsourcing, healthcare-providers and payor-services.
- Stages
- Series C+, buyout
- Sectors
- Healthcare, life-sciences-outsourcing, healthcare-providers, payor-services
- Check size
- $50M–$150M
- Invests in
- US-wide, UK
- Round role
- Leads rounds
- Actively investing
- Yes
- Founded
- 2015
- Assets under management
- $2.7B
- Website
- amuletcapital.com
Thesis
Amulet Capital Partners is a private equity firm founded in 2015, specializing in the healthcare sector with a focus on middle-market companies. They employ a thesis-driven investment strategy, targeting opportunities in life sciences outsourcing, healthcare providers, and payor/payor services. The firm seeks to invest at the intersection of operational excellence and durable market trends, aiming to build industry leaders through strategic growth and long-term value creation. Their sourcing is thematic, rooted in emerging trends and structural shifts within healthcare. Amulet Capital Partners prefers to invest in companies where complexity creates opportunity, often engaging in complex deals, off-market transactions, and bespoke structures. They emphasize a hands-on approach to value creation, supported by a network of healthcare operators, advisors, and experts. The firm manages approximately $2.7 billion in AUM and is currently investing out of its third fund, which closed at $1.2 billion. Their typical investment size ranges from $50 million to $150 million.
Common questions
Does AMULET CAPITAL PARTNERS, L.P. invest at the Series C+ stage?
Yes. AMULET CAPITAL PARTNERS, L.P. lists Series C+ and buyout among the stages it invests in.
What check size does AMULET CAPITAL PARTNERS, L.P. write?
AMULET CAPITAL PARTNERS, L.P. writes $50M–$150M checks.
Where does AMULET CAPITAL PARTNERS, L.P. invest?
AMULET CAPITAL PARTNERS, L.P. invests in the US and UK.